Sensei Biotherapeutics | ARS: Annual Report to Security Holders
Apr 30 04:46
Sensei Biotherapeutics | DEFA14A: Others
Apr 30 04:43
Sensei Biotherapeutics | DEF 14A: Definitive information statements
Apr 30 04:36
Sensei Biotherapeutics | 8-K: Current report
Apr 13 04:34
Sensei Biotherapeutics | 8-K: Current report
Apr 2 19:49
Sensei Biotherapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Newtyn Management, LLC(4.95%),Newtyn Capital Partners, LP(4.95%), etc.
Mar 8 07:06
Sensei Biotherapeutics | 8-K: Current report
Mar 6 05:52
Sensei Biotherapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Mar 1 11:33
Sensei Biotherapeutics | 10-K: Annual report
Mar 1 11:32
Sensei Biotherapeutics | 8-K: Current report
Feb 28 20:32
Sensei Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer van der Horst Edward
Feb 17 07:42
Sensei Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Celebi John
Feb 17 07:32
Sensei Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Colgan Erin
Feb 17 07:27
Sensei Biotherapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Newtyn Management, LLC(5.83%),Newtyn Capital Partners, LP(5.83%), etc.
Feb 14 06:39
Sensei Biotherapeutics | 8-K: Current report
Feb 9 05:38
Sensei Biotherapeutics | 8-K: Current report
Jan 4 13:00
Sensei Biotherapeutics: Q3 2023 Earnings Report
Nov 8, 2023 05:40
Sensei Biotherapeutics | 8-K: Sensei Biotherapeutics Reports Third Quarter 2023 Financial Results and Recent Business Highlights
Nov 7, 2023 20:35
Sensei Biotherapeutics | 8-K: Current report
Nov 6, 2023 19:07
Sensei Biotherapeutics | SC 13D: Statement of acquisition of beneficial ownership by individuals-Newtyn Management, LLC(6.5%),Newtyn Capital Partners, LP(6.5%), etc.
Nov 4, 2023 05:03
No Data
No Data